STREAMING NOW: Watch Now

Treatment combo nearly doubles survival time in lung cancer patients, study finds

Combining an immunotherapy drug with chemotherapy nearly doubled the survival time of some lung cancer patients compa...

Posted: Apr 16, 2018 2:00 PM
Updated: Apr 16, 2018 2:00 PM

Combining an immunotherapy drug with chemotherapy nearly doubled the survival time of some lung cancer patients compared to patients treated with chemotherapy alone, new research published Monday in the New England Journal of Medicine showed.

The study results apply only to patients whose lung cancer does not begin in the squamous cells (or surface lung cell layer) and who also lack certain genetic mutations. Of the two types of lung cancer, small cell lung cancer is less common than non-small cell lung cancer, which affects up to 85% of all lung cancer patients. Worldwide, lung cancer causes 1.69 million deaths annually.

Non-small cell lung cancer is the leading cause of cancer death in the world

Immunotherapy plus chemotherapy nearly doubled survival of patients with advanced disease

"Non-small cell lung cancer is actually the leading cause of cancer death in the world even though it's not the most common cancer," said Dr. Leena Gandhi, lead investigator of the study and director of the thoracic medical oncology program at Perlmutter Cancer Center at NYU Langone Health.

Gandhi explained that the reason non-small cell lung cancer is so deadly is the existing chemotherapy drugs provide only limited survival benefits for patients. "A matter of months, not years," she said.

Immunotherapy, which harnesses the body's immune system to attack tumors, is known to improve survival in patients who have already been treated with chemo.

Gandhi wondered, Would using immunotherapy earlier in treatment, alongside chemotherapy, do more for patients?

The study, a phase III clinical trial testing treatment effectiveness and side effects, included 616 patients at 118 medical facilities around the globe.

One group of 400 patients received standard chemotherapy and the immunotherapy drug pembrolizumab, while a smaller group of patients received chemotherapy.

Pembrolizumab, sold under the brand name Keytruda, is an FDA-approved drug sold by a subsidiary of Merck & Company, Inc. that sponsored this study.

The combined use of standard chemotherapy with pembrolizumab was "superior in terms of response -- keeping people alive without progression of their cancer -- and improving the overall survival of patients with metastatic lung cancer compared to chemotherapy alone," said Gandhi. "And the differences were not small."

For patients receiving the combined therapy, the chance of death or progression of their cancer was reduced by 48% compared to the patients receiving only chemotherapy. The most common side effects were nausea, anemia and fatigue and in both groups about 65% of patients experienced severe side effects. However, the risk of one side effect, acute kidney injury, was higher for combination treated patients: 5.2% vs. 0.5%.

Dr. Jorge Gomez, a volunteer spokesperson for the American Lung Association and a medical oncologist and director of thoracic oncology at Mount Sinai Hospital in New York, explained that "about 220,000 patients are diagnosed with lung cancer a year in the US."

Non-squamous lung cancer patients make up about 80% of all the non-small cell lung cancers, so that amounts to over 150,000 patients in the US each year, said Gomez, who was not involved in the new study.

"What we look at in these trials is overall survival -- how long patients live -- and we look at a number called the median survival -- how long 50% of patients live," said Gomez. Median survival is met when 50% of the patients die.

For non-squamous non-small cell lung cancer patients, median survival with chemotherapy alone is somewhere around 11 or 12 months, he said. Yet, median survival among the study participants who received both immunotherapy and chemo has not yet been reached.

"It's already been 21 months," said Gomez. "The differences are big enough now that you know it's going to be a very big number and it's important to get this information to people so they can start using this regimen."

Gomez believes it could be as high as double chemotherapy alone, "which would be very impressive," he said. "I only treat lung cancer and I've been doing that for about 20 years. These drugs are very, very interesting. Now, not everybody benefits unfortunately, but some of the people who benefit seem to benefit in a way we've never seen."

Recalling a patient with advanced lung cancer whose tumor disappeared and has not grown back after finishing treatment 24 months ago, Gomez said, "I'm now becoming much more optimistic that if we can really find a way to perfect this treatment and to really figure out who are the patients who do the best and why that we may be able to do something like get rid of lung cancer for at least some patients."

Huntsville
Scattered Clouds
90° wxIcon
Hi: 89° Lo: 68°
Feels Like: 94°
Florence
Broken Clouds
90° wxIcon
Hi: 88° Lo: 67°
Feels Like: 92°
Fayetteville
Scattered Clouds
86° wxIcon
Hi: 87° Lo: 65°
Feels Like: 89°
Decatur
Broken Clouds
90° wxIcon
Hi: 89° Lo: 66°
Feels Like: 93°
Scottsboro
Broken Clouds
81° wxIcon
Hi: 88° Lo: 69°
Feels Like: 89°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Confirmed Cases: 91776

Reported Deaths: 1639
CountyConfirmedDeaths
Jefferson12186230
Mobile9269204
Montgomery6350148
Madison512227
Tuscaloosa400269
Baldwin332223
Shelby311932
Marshall300134
Unassigned287856
Lee255442
Morgan227015
Etowah196728
DeKalb172113
Elmore163337
Calhoun162713
Walker147964
Houston133412
Dallas129823
Russell12672
St. Clair125214
Limestone122713
Franklin121520
Cullman117112
Colbert112213
Lauderdale111113
Autauga103021
Escambia98115
Talladega94613
Jackson8904
Chambers83238
Tallapoosa82778
Dale79823
Butler75435
Blount7453
Chilton7386
Coffee7255
Covington71620
Pike6727
Barbour5645
Lowndes56124
Marion54724
Marengo52914
Clarke4919
Hale45926
Bullock44411
Winston43511
Perry4324
Wilcox41110
Monroe3964
Randolph39210
Bibb3844
Pickens3769
Conecuh37310
Sumter36018
Lawrence3251
Macon31613
Washington31512
Crenshaw3073
Choctaw27612
Cherokee2497
Greene24711
Henry2473
Geneva2430
Clay2255
Lamar2052
Fayette1785
Cleburne1211
Coosa952
Out of AL00

Tennessee Coronavirus Cases

Confirmed Cases: 114098

Reported Deaths: 1144
CountyConfirmedDeaths
Shelby21924298
Davidson19812208
Rutherford625453
Hamilton580347
Knox418638
Williamson336322
Sumner326471
Unassigned29285
Out of TN279314
Wilson215223
Montgomery178113
Bradley177112
Sevier17636
Putnam164613
Trousdale15766
Robertson147519
Hamblen131113
Blount11868
Tipton11379
Washington11142
Maury11077
Madison95714
Bedford89011
Sullivan85911
Macon84713
Hardeman84312
Lake7580
Loudon6863
Bledsoe6741
Fayette6468
Anderson6376
Dickson6301
Gibson6152
Dyer5797
Cheatham5546
Rhea5141
Jefferson5133
McMinn49820
Lawrence4976
Henderson4830
Obion4644
Warren4544
Carter4525
Coffee4482
Lauderdale4457
Hardin4267
Cocke4212
Haywood4145
Greene3986
Roane3982
Cumberland3976
Smith3933
Hawkins3915
Monroe3809
Giles36012
McNairy3355
Weakley3293
DeKalb3261
Franklin2964
Marshall2713
Lincoln2591
Carroll2513
Crockett2464
Hickman2400
Claiborne2350
White2323
Henry2310
Campbell2241
Wayne2222
Johnson2140
Marion2104
Chester2012
Grainger1810
Polk1813
Decatur1742
Overton1411
Unicoi1410
Union1330
Cannon1310
Humphreys1133
Benton1111
Jackson1091
Scott1050
Grundy1042
Meigs990
Sequatchie960
Morgan941
Perry770
Fentress760
Hancock761
Stewart720
Clay660
Lewis621
Houston540
Moore530
Van Buren330
Pickett271

Community Events